Terms ending in 2031
Every in-force patent on CVRX, Inc.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,214,050 | Method for Monitoring Physiological Cycles of a Patient to Optimize Patient Therapy In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 9,026,215 | Hypertension treatment device and method for mitigating rapid changes in blood pressure In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 8,437,867 | Implant Tool and Improved Electrode Design for Minimally Invasive Procedure In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 8,788,066 | Implant Tool and Improved Electrode Design for Minimally Invasive Procedure In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 9,511,218 | Implant Tool and Improved Electrode Design for Minimally Invasive Procedure In force · Medium confidence | CVRX, Inc. | In force | Medium confidence | |
| US 10,350,406 | Implant Tool and Improved Electrode Design for Minimally Invasive Procedure In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 11,058,869 | Implant Tool and Improved Electrode Design for Minimally Invasive Procedure In force · High confidence | CVRX, Inc. | In force | High confidence | |
| US 12,496,439 | Implant Tool and Improved Electrode Design for Minimally Invasive Procedure In force · Medium confidence | CVRX, Inc. | In force | Medium confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.